The Board in its meeting held on July 29, 2025, had approved the unaudited financial results for the quarter ended June 30, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts less than Nifty Microcap 250 and 2.2 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Directors of National Peroxide Ltd met on July 29, 2025, and approved the unaudited financial results for the quarter ended June 30, 2025. Revenue from operations fell to ₹6,665.52 lakhs from ₹7,398.85 lakhs in the same quarter last year, a decline of nearly 10%. The company reported a loss after tax of ₹224.64 lakhs in Q1 FY26, though this was a sharp improvement from a loss of ₹649.01 lakhs in Q1 FY25. EPS stood at negative ₹3.91 versus negative ₹11.29 a year ago. The auditor Kalyaniwalla & Mistry LLP issued a clean limited review report with no qualifications. The Board also fixed the 5th AGM for September 4, 2025 via video conferencing.
While the loss narrowed significantly year-on-year, the company remains in the red with shrinking top-line revenues, which is a concern for shareholders. The clean auditor review and reduced losses offer some comfort, but investors should watch for revenue stabilisation in coming quarters.